S100B has been shown to increase in cerebrospinal fluid (CSF) and serum after various neurological diseases (for example, trauma, stroke, inflammation, bacterial and viral meningitis) and it has been postulated that S100B could serve as a serum marker for brain damage. The gene discussed is S100B; the disease is nervous system disorder.